CAR T CELL THERAPY
Clinical trials for CAR T CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy targets tough leukemia in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called A-CAR028 for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses specially engineered immune cells (CAR-T cells) to find and attack cancer cells. The main goals ar…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 26, 2026 02:24 UTC
-
Engineered immune cells take on aggressive MS in first human trial
Disease control Recruiting nowThis study tests a new treatment called MB-CART2019.1 for people with active multiple sclerosis (MS) that has not responded to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target and attack harmful immune cells driving MS. The goal is …
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1, PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 26, 2026 02:13 UTC
-
Engineered immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis study tests a new treatment for people with a fast-growing blood cancer called diffuse large B cell lymphoma that has come back or not responded to at least two prior therapies. The treatment uses the patient's own immune cells, which are genetically modified to recognize an…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New CAR-T therapy targets tough lung cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called TC-D101 for people with a specific type of advanced small cell lung cancer that has not responded to standard therapies. The treatment uses specially engineered immune cells (CAR-T cells) to target a protein called DLL3 on cance…
Matched conditions: CAR T CELL THERAPY
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New app aims to ease CAR-T journey for cancer patients
Symptom relief Recruiting nowThis study tests whether a mobile app called THRIVE-CAR-T helps people going through CAR-T cell therapy. About 100 adults with blood cancer will use the app to see if it is practical and acceptable. The goal is to improve support during treatment, not to cure the disease.
Matched conditions: CAR T CELL THERAPY
Phase: NA • Sponsor: Patrick C. Johnson, MD • Aim: Symptom relief
Last updated May 26, 2026 02:23 UTC
-
New program helps transplant survivors fight fatigue and pain with coping skills and step coaching
Symptom relief Recruiting nowThis study tests a program called Step Up that combines in-person and app-based coping skills training with activity coaching. It aims to help people who have had a stem cell transplant or CAR-T therapy for blood cancer better manage symptoms like pain, fatigue, and stress, so th…
Matched conditions: CAR T CELL THERAPY
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 22, 2026 13:55 UTC
-
New study aims to predict brain complications from CAR T-Cell therapy
Knowledge-focused Recruiting nowThis study looks at why some people getting CAR T-cell therapy for cancer develop brain-related side effects called neurotoxicity. Researchers will use brain scans, thinking tests, and blood tests to find early warning signs. The goal is to create a tool that can predict who is a…
Matched conditions: CAR T CELL THERAPY
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC